Inotiv Class Action Lawsuit NOTV | Deadline August 22, 2022
Inotiv Class Action Lawsuit (NOTV Lawsuit)
The Gross Law Firm notifies investors that a class action (Inotiv Class Action Lawsuit) has commenced in the United States District Court for the Northern District of Indiana on behalf of shareholders of Inotiv, Inc. (NOTV) who purchased shares between September 21, 2021 and June 13, 2022.
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) NOTV’s acquisition, Envigo RMS, LL (“Envigo”), and Inotiv’s Cumberland, Virginia facility (the “Cumberland Facility”) engaged in widespread and flagrant violations of the Animal Welfare Act (“AWA”); (2) Envigo and NOTV’s Cumberland Facility continuously violated the AWA; (3) Envigo and NOTV did not properly remedy issues with regards to animal welfare at the Cumberland Facility; (4) as a result, NOTV was likely to face increased scrutiny and governmental action; (5) NOTV would imminently shut down two facilities, including the Cumberland Facility; (6) NOTV did not engage in proper due diligence; and (7) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action. Appointment as Lead Plaintiff is not required to partake in any recovery.
Shareholders have until August 22, 2022 to request that the court appoint them lead plaintiff.
Inotiv Class Action
On behalf of investors who bought or otherwise acquired the publicly traded securities of Inotiv, Inc. (“Inotiv” or the “Company”) (NASDAQ: NOTV) between September 21, 2021 and June 13, 2022, inclusive (the “Class Period”), Bernstein Liebhard LLP, a renowned national investor rights law firm, reminds investors of the deadline for filing a lead plaintiff motion. The Securities Exchange Act of 1934 is allegedly violated, and the complaint was brought in the United States District Court for the Northern District of Indiana.
Levi & Korsinsky, LLP (Newsfile Corp. – August 16, 2022)
informs Inotiv, Inc. (NASDAQ: NOTV) stockholders (“Inotiv” or the “Company”)
of a securities class action lawsuit. The case has been filed in the United States District Court for the Northern District of Indiana on behalf of Inotiv investors. Between September 21, 2021 and June 13, 2022, affected investors purchased or otherwise acquired certain Inotiv, Inc. securities.
NOTV Class Action Lawsuit
The Animal Welfare Act of 1966 (“AWA”) was repeatedly and flagrantly violated by Envigo and Inotiv’s Cumberland, Virginia facility, according to the Inotiv class action lawsuit. It also claims that Envigo and Inotiv’s Cumberland facility consistently violated the AWA. Finally, the lawsuit claims that Envigo and Inotiv failed to adequately address animal welfare concerns at the Cumberland facility throughout the Class Period.
NOTV Class Action
Any investor who bought Inotiv stocks during the Class Period may request appointment as lead plaintiff under the Private Securities Litigation Reform Act of 1995. A lead plaintiff is typically the petitioner who has the largest financial stake in the remedy the putative class is seeking and who is also representative and sufficient of the putative class. In the Inotiv class action case, a lead plaintiff leads on behalf of all other class members. The Inotiv class action case can be litigated by the lead plaintiff’s choice of law firm. It is not necessary to be the lead plaintiff in the Inotiv class action case in order for an investment to be eligible to partake in any potential future recovery.
SAN DIEGO-(BUSINESS WIRE)-$NOTV #Inotiv—The Class: Investors are reminded that a shareholder filed a class action on behalf of all individuals and entities that bought or otherwise acquired Inotiv, Inc. (NASDAQ: NOTV) securities between September 21, 2021 and June 13, 2022 for violations of the Securities Exchange Act of 1934. Shareholder rights law firm Robbins LLP is representing the plaintiffs in this case. According to its website, Inotiv is a company that performs contract research and offers nonclinical and analytical drug discovery and development services, research models, and related goods and services.
An multinational contract research organization called Inotiv, Inc. specializes in offering analytical tools and services for medication development and discovery. The Company specializes in offering analytical tools and scientific research to drug developers. Contract Research Services and Research Products are the Company’s two business segments. The Contract Research Services division offers pharmacological testing, formulation development, regulatory compliance, quality control testing, screening testing, and nonclinical safety testing. Analytical products and in vivo sampling products are two of the main product categories offered by the research products division. Liquid chromatographic and electrochemical instruments, along with any necessary accessories, make up analytical products. The Culex line of automated in vivo sampling and dosing instruments makes up in vivo sampling products.
To receive more information, please fill out the form.
Inotiv, Inc. Class Action Lawsuit
Inotiv, Inc. Lawsuit
NOTV Class Action Lawsuit
Inotiv, Inc. (NOTV) Class Action Lawsuit
Inotiv Class Action Lawsuit,
Inotiv Class Action,
NOTV Class Action Lawsuit,
NOTV Class Action,